Condition
ER+/HER2- Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 ER+/HER2- Breast Cancer clinical trials that are recruiting, in China. By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Combining high-intensity focused ultrasound with immunotherapy and chemotherapy for breast cancer treatment
This study is testing if combining high-intensity focused ultrasound with immunotherapy and chemotherapy can help women with a specific type of breast cancer more than just chemotherapy alone.
-
Testing FWD1802 for ER+/HER2- breast cancer
This study is testing a new treatment called FWD1802, alone and with another drug, to see if it can help people with advanced ER+/HER2- breast cancer feel better and improve their outcomes.
Related topics
Quick answers
How many ER+/HER2- Breast Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.